BANK OF AMERICA CORP /DE/

Holdings History for Revance Therapeutics, Inc. - COM (RVNC)

Symbol: RVNC on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	+0%	$973K	187K	+7,481	+4.16%	$5.19	Q3 2024
6/30/2024	0%	0%	$462K	180K	-324,725	-64.3%	$2.57	Q2 2024
3/31/2024	0%	+0%	$2.48M	505K	+296,003	+142%	$4.92	Q1 2024
12/31/2023	0%	+0%	$1.83M	209K	+87,764	+72.6%	$8.79	Q4 2023
9/30/2023	0%	0%	$1.39M	121K	-161,237	-57.1%	$11.47	Q3 2023
6/30/2023	0%	0%	$7.14M	282K	-7,854	-2.71%	$25.31	Q2 2023
3/31/2023	0%	+0%	$9.34M	290K	+114,091	+64.9%	$32.21	Q1 2023
12/31/2022	0%	0%	$3.25M	176K	-253,552	-59%	$18.46	Q4 2022
9/30/2022	0%	+0%	$11.6M	429K	+324,649	+310%	$27.00	Q3 2022
6/30/2022			$1K	100			$10.00^*	Q2 2022
6/30/2022	0%	+0%	$1.45M	105K	+69,960	+201%	$13.82	Q2 2022
3/31/2022	0%	0%	$680K	34.9K	-76,575	-68.7%	$19.51	Q1 2022
12/31/2021			$2K	100			$20.00^*	Q4 2021
12/31/2021	0%	+0%	$1.82M	111K	+40,913	+58%	$16.32	Q4 2021
9/30/2021	0%	+0%	$1.97M	70.5K	+1,193	+1.72%	$27.87	Q3 2021
6/30/2021	0%	0%	$2.06M	69.3K	-1,985	-2.78%	$29.66	Q2 2021
3/31/2021	0%	+0%	$1.99M	71.3K	+10,702	+17.7%	$27.95	Q1 2021
12/31/2020	0%	0%	$1.72M	60.6K	-28,021	-31.6%	$28.35	Q4 2020
9/30/2020	0%	+0%	$2.23M	88.6K	+31,578	+55.4%	$25.14	Q3 2020
6/30/2020	0%	+0%	$1.39M	57K	+3,186	+5.92%	$24.42	Q2 2020
3/31/2020	0%	+0%	$797K	53.9K	+22,192	+70.1%	$14.80	Q1 2020
12/31/2019	0%	0%	$514K	31.7K	-10,727	-25.3%	$16.23	Q4 2019
9/30/2019	0%		$551K	42.4K	-199	-0.47%	$13.00	Q3 2019
6/30/2019	0%	0%	$553K	42.6K	-39,728	-48.3%	$12.98	Q2 2019
3/31/2019	0%	+0%	$1.3M	82.3K	+33,294	+67.9%	$15.76	Q1 2019
12/31/2018	0%	0%	$987K	49K	-33,571	-40.6%	$20.13	Q4 2018
9/30/2018	0%	0%	$2.05M	82.6K	-38,133	-31.6%	$24.84	Q3 2018
6/30/2018			$1K	24			$41.67^*	Q2 2018
6/30/2018	0%	+0%	$3.31M	121K	+90,224	+296%	$27.45	Q2 2018
3/31/2018	0%	+0%	$940K	30.5K	+21,048	+222%	$30.81	Q1 2018
12/31/2017			$1K	22			$45.45^*	Q4 2017
12/31/2017	0%	0%	$338K	9.46K	-512	-5.13%	$35.73	Q4 2017
9/30/2017	0%	+0%	$275K	9.97K	+4,227	+73.6%	$27.57	Q3 2017
6/30/2017	0%	0%	$151K	5.75K	-1,501	-20.7%	$26.28	Q2 2017
3/31/2017	0%	+0%	$151K	7.25K	+1,651	+29.5%	$20.84	Q1 2017
12/31/2016	0%	+0%	$116K	5.6K	+3,079	+122%	$20.73	Q4 2016
9/30/2016	0%	0%	$41K	2.52K	-1,075	-29.9%	$16.29	Q3 2016
6/30/2016	0%	+0%	$49K	3.59K	+1,925	+115%	$13.64	Q2 2016
3/31/2016	0%	0%	$29K	1.67K	-14,259	-89.5%	$17.40	Q1 2016
12/31/2015	0%	+0%	$544K	15.9K	+14,670	+1168%	$34.16	Q4 2015
9/30/2015	0%	0%	$38K	1.26K	-1,200	-48.9%	$30.25	Q3 2015
6/30/2015	0%	+0%	$79K	2.46K	+1,456	+146%	$32.17	Q2 2015
3/31/2015			$1K	28			$35.71^*	Q1 2015
3/31/2015	0%	0%	$21K	1K	-3,400	-77.3%	$21.00	Q1 2015
12/31/2014	0%	+0%	$75K	4.4K	+3,031	+221%	$17.05	Q4 2014
9/30/2014	0%		$26K	1.37K	+32	+2.39%	$18.99	Q3 2014
6/30/2014	0%	+0%	$45K	1.34K	+337	+33.7%	$33.66	Q2 2014
3/31/2014	0%	+0%	$32K	1K	+1,000	NEW	$32.00	Q1 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.